| scholarly article | Q13442814 |
| P2093 | author name string | Rishindra M Reddy | |
| Sandra L Wong | |||
| Mark A Healy | |||
| Huiying Yin | |||
| P2860 | cites work | The meaning and use of the area under a receiver operating characteristic (ROC) curve | Q29547182 |
| Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance. | Q34223299 | ||
| Geographic variation in cancer-related imaging: Veterans Affairs health care system versus Medicare | Q34610342 | ||
| The lack of evidence for PET or PET/CT surveillance of patients with treated lymphoma, colorectal cancer, and head and neck cancer: a systematic review | Q34775441 | ||
| Regional-Level Correlations in Inappropriate Imaging Rates for Prostate and Breast Cancers: Potential Implications for the Choosing Wisely Campaign | Q36450040 | ||
| The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry | Q40027009 | ||
| Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer. | Q42178065 | ||
| Clinical decisions associated with positron emission tomography in a prospective cohort of patients with suspected or known cancer at one United States center | Q44905774 | ||
| Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry | Q44937043 | ||
| Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry | Q44942846 | ||
| Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. | Q46435513 | ||
| 2014 Cassen Lecture: What have we learned from the National Oncologic PET Registry? | Q48519484 | ||
| Traditional multiplicity adjustment methods in clinical trials. | Q51152686 | ||
| American Society of Clinical Oncology 2013 top five list in oncology. | Q53090281 | ||
| Diagnostic Imaging Use for Patients With Cancer: Opportunities to Enhance Value | Q85609057 | ||
| SNMMI comment on ASCO 2013 "Choosing wisely" recommendation on use of PET/CT in recurrent cancer surveillance | Q87513304 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | positron emission tomography | Q208376 |
| P577 | publication date | 2016-02-22 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Use of Positron Emission Tomography to Detect Recurrence and Associations With Survival in Patients With Lung and Esophageal Cancers | |
| P478 | volume | 108 |
| Q90062805 | Ethnic Disparities in PET/CT Utilization at Diagnosis of Non-Small Cell Lung Cancer |
| Q43285072 | Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillance. |
| Q57795877 | The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera |
| Q37162301 | Value-Based Care in Lung Cancer |
Search more.